Hindson Benjamin J.'s Form 4 filing
10x Genomics, Inc. (TXG) · filed Jul 6, 2021
- Accession no.
- 0001209191-21-045469
- Filed
- Jul 6, 2021
- Trade date
- Jul 1, 2021
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $7.98M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hindson Benjamin J.CIK 0001786391 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 | Class A Common Stock | MOption exerciseAcquired | +41,666 | $1.20 | +$49,999.2 | 89,120 | Direct | |
| Jul 1, 2021 | Class A Common Stock | SSaleDisposed | −9,058 | $189.80F2 | −$1,719,208.4 | 80,062 | Direct | |
| Jul 1, 2021 | Class A Common Stock | SSaleDisposed | −12,845 | $190.51F3 | −$2,447,100.95 | 67,217 | Direct | |
| Jul 1, 2021 | Class A Common Stock | SSaleDisposed | −7,202 | $191.58F4 | −$1,379,759.16 | 60,015 | Direct | |
| Jul 1, 2021 | Class A Common Stock | SSaleDisposed | −2,872 | $192.69F5 | −$553,405.68 | 57,143 | Direct | |
| Jul 1, 2021 | Class A Common Stock | SSaleDisposed | −5,989 | $193.63F6 | −$1,159,650.07 | 51,154 | Direct | |
| Jul 1, 2021 | Class A Common Stock | SSaleDisposed | −2,500 | $194.58F7 | −$486,450 | 48,654 | Direct | |
| Jul 1, 2021 | Class A Common Stock | SSaleDisposed | −1,200 | $195.60F8 | −$234,720 | 47,454 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 | Class A Common Stock | MOption exerciseDisposed | −41,666 | $0.00 | $0 | 71,082 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $189.14 to $190.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $190.14 to $191.09. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $191.14 to $192.105. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $192.14 to $193.085. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $193.15 to $194.14. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $194.17 to $195.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $195.23 to $196.05. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
Remarks
Chief Scientific Officer and President